Plantable Health Inc.

Plantable Health's Trial at Memorial Sloan Kettering Aims to Reduce Risk Factors Associated With Breast Cancer

New York, New York--(Newsfile Corp. - March 8, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today provides an update in light of International Women's Day on its Breast Cancer Trial at the Memorial Sloan Kettering Cancer Center ("MSK"), which aims to study the efficacy of Plantable as a whole food plant-based dietary intervention to help reduce the independent risk factors associated with breast cancer and other metabolic markers associated with chronic disease....

2022-03-08 8:45 AM EST

Plantable Health's Clinical Trials Aim to Revolutionize U.S. Healthcare

New York, New York--(Newsfile Corp. - March 2, 2022) - Plantable Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today provides an update on its clinical trials which are expected to further validate Plantable's Reboot program as a clinically-proven program to optimize health, and address the epidemic of chronic disease including obesity, high cholesterol, diabetes and certain cancers. With 6 out of 10 people in the US suffering from chronic disease[1], healthcare costs are...

2022-03-02 8:45 AM EST

Plantable Health Announces Investor Relations Agreement with Apollo Shareholder Relations

New York, New York--(Newsfile Corp. - February 15, 2022) - Plantable Health Inc. (NEO: PLBL) ("Plantable" or the "Company"), today announces that is has entered into an investor relations service agreement (the "IR Agreement") with Apollo Shareholder Relations ("Apollo"), a full-service investor communications agency with a specific focus on the modern investor.

2022-02-15 8:45 AM EST

Plantable Health Bolsters Executive Team To Foster Growth and Expansion

New York, New York--(Newsfile Corp. - February 3, 2022) - Plantable Health Inc. (NEO: PLBL) ("Plantable" or the "Company"), a leader in clinically-supported holistic healthcare programs that leverage behavioural coaching, immersive software and whole food plant-based nutrition today announced key additions to its executive team as the Company embarks on its aggressive growth strategy.Plantable

2022-02-03 8:45 AM EST

Plantable Health Expands Into Rapidly Growing Digital Health Industry Through App Launch

Vancouver, British Columbia--(Newsfile Corp. - January 18, 2022) - Plantable Health Inc. (NEO: PLBL) ("Plantable" or the "Company"), a leader in clinically supported plant-based nutrition and digital health programs, announced today that it has launched its first digital product with the introduction of its lifestyle app. The Plantable App (the "App") is the Company's first expansion outside of the United States and marks the first phase of its digital health initiatives. The App is now...

2022-01-18 8:45 AM EST

Plantable Health Announces Public Listing on NEO Exchange

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2022) - Plantable Health Inc. (NEO: PLBL) ("Plantable" or the "Company"), announced today that the Company's common shares will commence trading on the NEO Exchange Inc. (the "NEO"), as of market open on January 12, 2022, under the symbol "PLBL."As part of its investor awareness program, Plantable is pleased to announce that it has retained Hybrid Financial Ltd. ("Hybrid") to provide marketing services to the Company for an initial...

2022-01-12 8:45 AM EST

Plantable Health Completes Initial Public Offering

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2021) - Plantable Health Inc. ("Plantable" or the "Company"), announced today the successful closing of its initial public offering (the "Offering") of units of Plantable ("Units") at a price of C$0.40 (the "Offering Price") per Unit for gross proceeds of C$4.5 million. Clarus Securities Inc. (the "Agent") acted as sole agent and bookrunner in respect of the Offering.CEO Dr. Nadja Pinnavaia stated: The IPO is a critical milestone...

2021-12-31 11:11 AM EST